Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in Computational Techniques to Study GPCR-Ligand Recognition.
Ciancetta A, Sabbadin D, Federico S, Spalluto G, Moro S. Ciancetta A, et al. Among authors: spalluto g. Trends Pharmacol Sci. 2015 Dec;36(12):878-890. doi: 10.1016/j.tips.2015.08.006. Epub 2015 Nov 1. Trends Pharmacol Sci. 2015. PMID: 26538318 Free article. Review.
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies.
Baraldi PG, Cacciari B, Moro S, Romagnoli R, Ji Xd, Jacobson KA, Gessi S, Borea PA, Spalluto G. Baraldi PG, et al. Among authors: spalluto g. J Med Chem. 2001 Aug 16;44(17):2735-42. doi: 10.1021/jm010818a. J Med Chem. 2001. PMID: 11495585
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor containing a tyrosine moiety.
Baraldi PG, Makaeva R, Pavani MG, Nuñez Mdel C, Spalluto G, Moro S, Falzoni S, Di Virgilio F, Romagnoli R. Baraldi PG, et al. Among authors: spalluto g. Arzneimittelforschung. 2002;52(4):273-85. doi: 10.1055/s-0031-1299891. Arzneimittelforschung. 2002. PMID: 12040970
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA. Pastorin G, et al. Among authors: spalluto g. J Med Chem. 2003 Sep 25;46(20):4287-96. doi: 10.1021/jm030852k. J Med Chem. 2003. PMID: 13678407
Hemolytic effects of water-soluble fullerene derivatives.
Bosi S, Feruglio L, Da Ros T, Spalluto G, Gregoretti B, Terdoslavich M, Decorti G, Passamonti S, Moro S, Prato M. Bosi S, et al. Among authors: spalluto g. J Med Chem. 2004 Dec 30;47(27):6711-5. doi: 10.1021/jm0497489. J Med Chem. 2004. PMID: 15615520
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.
Moro S, Braiuca P, Deflorian F, Ferrari C, Pastorin G, Cacciari B, Baraldi PG, Varani K, Borea PA, Spalluto G. Moro S, et al. Among authors: spalluto g. J Med Chem. 2005 Jan 13;48(1):152-62. doi: 10.1021/jm049662f. J Med Chem. 2005. PMID: 15634009
128 results